An overview of some potential immunotherapeutic options against COVID-19

After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despite relentless efforts to control the disease by drug repurposing, there is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Immunopharmacol
Autors principals: Bayat, Maryam, Asemani, Yahya, Mohammadi, Mohammad Reza, Sanaei, Mahsa, Namvarpour, Mozhdeh, Eftekhari, Reyhaneh
Format: Artigo
Idioma:Inglês
Publicat: Elsevier B.V. 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908848/
https://ncbi.nlm.nih.gov/pubmed/33765610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107516
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars